Elsevier

Journal of Ethnopharmacology

Volume 88, Issue 1, September 2003, Pages 107-111
Journal of Ethnopharmacology

Antihyperglycemic effects of three extracts from Momordica charantia

https://doi.org/10.1016/S0378-8741(03)00184-3Get rights and content

Abstract

Momordica charantia (L.) (Cucurbitaceae) commonly known as bitter gourd or karela is a medicinal plant, used in Ayurveda for treating various diseases, one of which is diabetes mellitus. In this study, various extract powders of the fresh and dried whole fruits were prepared and their blood glucose lowering effect compared by administrating them orally to diabetic rats. The aqueous extract powder of fresh unripe whole fruits at a dose of 20 mg/kg body weight was found to reduce fasting blood glucose by 48%, an effect comparable to that of glibenclamide, a known synthetic drug. This extract was tested for nephrotoxicity, hepatotoxicity and biochemical parameters such as SGOT, SGPT and lipid profile. The extract did not show any signs of nephrotoxicity and hepatotoxicity as judged by histological and biochemical parameters. Thus the aqueous extract powder of Momordica charantia, an edible vegetable, appears to be a safe alternative to reducing blood glucose.

Introduction

Diabetes is a disorder of carbohydrate, fat and protein metabolism attributed to diminished production of insulin or mounting resistance to its action. Chronic hyperglycemia during diabetes causes glycation of body proteins that in turn leads to secondary complications affecting eyes, kidneys, nerves and arteries (Sharma et al., 1993). These may be delayed, lessened or prevented by maintaining blood glucose values close to normal. Besides the use of insulin for the treatment of insulin dependent diabetes mellitus (IDDM), other approaches for the control of hyperglycemia include the use of amylin analogues which regulate gastric emptying and inhibitors of intestinal alpha glucosidases like acarbose, miglitol and voglibiose which delay postprandial hyperglycemia. Sulphonylureas, the most widely used class of drugs act by closure of ATP dependent channel. Metformin, a biguanide oral antibiotic limits intestinal glucose absorption. These drugs have certain effects like causing hypoglycemia at higher doses, liver problems, lactic acidosis and diarrhea. It is apparent that due to the side effects of the currently used drugs, there is a need for a safe agent with minimal adverse effects, which can be taken for long durations.

In addition to the above drugs of synthetic origin, many agents of plant origin are also in use particularly for the treatment of non-insulin dependent diabetes mellitus (NIDDM). Various medicinal plants like Momordica charantia L., Azardiracta indica and Ficus racemosa are known to possess antihyperglycemic activity (Atta-ur-Rahman, 1989). Extracts of the leaves of Gymnema sylvestris have been shown to induce beta cell regeneration (Baskaran et al., 1990). A galactomannan has been identified as the major constituent of the blood glucose lowering extract from Trigonella foenum-graecum (Ali et al., 1995). The hypoglycemia producing molecule of Pandanus odorus roots has been shown to be 4-hydroxy benzoic acid (Peungvicha et al., 1998). A pectin from the fruit of Coccinia indica significantly lowered blood glucose (Kumar et al., 1993).

For the present study Momordica charantia (L.) (Cucurbitaceae) was chosen since it is by far the most extensively investigated and most widely acclaimed remedy for treatment of diabetes mellitus since ancient times. Momordica charantia, also referred to as bitter gourd or karela, is a member of the Cucurbitaceae family and is commonly used as a traditional remedy for diabetes in India, Asia, Africa and South America. It is commonly consumed as a vegetable in India. The fruit, leaves, seeds and roots of Momordica charantia have been used in the Indian system of medicine for a number of diseases, besides diabetes. The unripe fruits of this plant have been shown to produce a hypoglycemic effect in experimental models following oral administration (Sharma et al., 1960, Akhtar et al., 1981, Srivastava et al., 1987, Day et al., 1990, Pugazhenthi et al., 1995). Many clinical trials have also confirmed the hypoglycemic action (Leatherdale et al., 1981). Some investigators have attempted to purify the active fractions from fruits of Momordica charantia in order to establish the precise mechanism of its hypoglycemic effects (Lotlikar and Rajarama Rao, 1966). But, most of these studies were restricted to very short durations and used a single large dose.

In the present study, extracts of the fresh and dried whole fruits were compared for their efficacies in lowering fasting blood glucose. The extract, which showed the maximum efficacy, was further investigated for hepato and nephrotoxicity during the experimental period.

Section snippets

Methods and materials

Green, unriped fresh fruits of Momordica charantia were purchased from the local market of Mumbai, India and identified by Blatter Herbarium, St. Xavier College, Mumbai, India. A voucher specimen (No. 5475 of Northern Island) has been kept in our laboratory for future reference. Part of fresh fruits were sun dried to get Momordica charantia fruit dried powder.

Alloxan and glibenclamide were obtained from Sigma Co., St. Louis, MO, USA. The glucose Oxidase–Peroxidase kits was purchased from Span

Results and discussion

As can seen from Table 1, though all three extract powders did lower blood glucose, the aqueous extract powder showed the maximum efficacy. The methanolic extract (A) reduced blood glucose by 49% at the end of the first week which became 39% at the end of the fourth week. While the chloroform extract (B) showed almost no antihyperglycemic activity (3%), the aqueous extract (C) showed a blood glucose lowering activity, which was 50% and stayed consistent till the end of the study. The

Conclusion

A systematic study of three extracts from Momordica charantia indicates that a water extract powder at doses as low as 20 mg/kg body weight can reverse alloxan induced hyperglycemia in rats with no toxicity to liver and kidneys up to a period of 4 weeks. Higher doses may not only be ineffective but may also cause toxicity. Thus Kulkarni and Gaitonde (1962) failed to observe any hypoglycemic response in rats fed bitter melon at 500 mg/kg body weight. The extract ameliorated loss in body weight in

References (15)

  • M.S. Akhtar et al.

    Effect of M. charantia on blood glucose level of normal and alloxan-diabetic rabbits

    Planta Medica

    (1981)
  • L. Ali et al.

    Characterization of the hypoglycemic effects of Trigonella foenum graecum seed

    Planta Medica

    (1995)
  • Atta-ur-Rahman et al.

    Medicinal plants with hypoglycemic activity

    Journal of Ethnopharmacology

    (1989)
  • K. Baskaran et al.

    Antidiabetic effect of a leaf extract from Gymnema sybestre in non insulin dependent diabetes mellitus

    Journal of Ethnopharmacology

    (1990)
  • C. Day et al.

    Hypoglycemic effect of M. charantia extracts

    Planta Medica

    (1990)
  • R.D. Kulkarni et al.

    Potentiation of tolbutamide action by Jasabhasma and M. charantia

    Journal of Indian Medical Association

    (1962)
  • G.P. Kumar et al.

    Hypoglycemic activity of Coccinia indica mechanism of action

    Planta Medica

    (1993)
There are more references available in the full text version of this article.

Cited by (240)

  • Anti-hyperglycemic activity of HPLC-fractionated Momordica charantia seed extract enriched in a novel napin-like protein in experimental diabetic rats and its validation with recombinant napin-like protein

    2022, Current Research in Biotechnology
    Citation Excerpt :

    Aerial parts of M. charantia, such as its fruits and seeds, have been used as alternative medicine in various parts of the world to treat diabetes. The fruit of M. charantia exhibits hypoglycemic activity in experimental animal models as well as in humans after oral administration, and has been demonstrated to be highly beneficial in maintaining normal blood glucose levels (Baldwa et al., 1977; Khanna et al., 1981; Leatherdale et al., 1981; Rahman et al., 2009; Virdi et al., 2003; Yibchok-anun et al., 2006). A recent randomized, double-blind placebo-controlled clinical trial using unripe fruit extract of M. charantia has revealed a promising glucose-lowering effect with no adverse events in patients with type 2 diabetes (Kim et al., 2020).

View all citing articles on Scopus
View full text